Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5389
-0.0103 (-1.87%)
May 14, 2025, 2:48 PM - Market open

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
717----
Upgrade
Enterprise Value
1325----
Upgrade
Last Close Price
0.551.45----
Upgrade
PB Ratio
1.502.31----
Upgrade
Debt / Equity Ratio
1.231.230.430.310.310.03
Upgrade
Asset Turnover
---0.00--
Upgrade
Quick Ratio
0.200.200.0100.000.07
Upgrade
Current Ratio
0.250.250.030.010.020.10
Upgrade
Return on Equity (ROE)
-139.55%-139.55%-14.46%-19.99%-4.52%-3.89%
Upgrade
Return on Assets (ROA)
-6.54%-6.54%-5.53%-4.13%-3.81%-2.32%
Upgrade
Return on Capital (ROIC)
-7.52%-7.52%-6.07%-4.47%-4.18%-2.61%
Upgrade
Earnings Yield
-375.13%-148.12%----
Upgrade
FCF Yield
-59.50%-23.49%----
Upgrade
Buyback Yield / Dilution
82.14%82.14%14.54%0.00%--
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q